48.34MMarket Cap
LossP/E TTM
Key Figures
2.110Open
2.230High
48.09KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.25%Turnover Ratio
2.140Prev. Close
2.090Low
81.93KTurnover
LossP/E Static
5.48P/B
0.00%Div Yield TTM
-31.71%ROA
12.30052wk High
0.49Volume Ratio
-12.91MNet Profit
19.62MShares
-0.5864EPS TTM
-8.58Beta
-103.29%ROE
3.16052wk Low
6.54%Amplitude
59.21%Gross Margin
48.34MMarket Cap
-5.34Reward/Risk
4.76%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Bioharvest Sciences Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 34 out of 94 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.75.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bioharvest Sciences Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Bioharvest Sciences Inc Highlights
StrengthsRisks
Bioharvest Sciences Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Bioharvest Sciences Inc
BHST
4
Mondelez International Inc
MDLZ
27
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bioharvest Sciences Inc Info
BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Ticker SymbolBHST
CompanyBioharvest Sciences Inc
CEOSobel (Ilan)
Websitehttps://bioharvest.com/about/
Shareholders
FAQs
What is the current price of Bioharvest Sciences Inc (BHST)?
The current price of Bioharvest Sciences Inc (BHST) is 2.21.
What is the symbol of Bioharvest Sciences Inc?
The ticker symbol of Bioharvest Sciences Inc is BHST.
What is the 52-week high of Bioharvest Sciences Inc?
The 52-week high of Bioharvest Sciences Inc is 12.30.
What is the 52-week low of Bioharvest Sciences Inc?
The 52-week low of Bioharvest Sciences Inc is 3.16.
What is the market capitalization of Bioharvest Sciences Inc?
The market capitalization of Bioharvest Sciences Inc is 43.35M.
Is Bioharvest Sciences Inc (BHST) currently rated as Buy, Hold, or Sell?
According to analysts, Bioharvest Sciences Inc (BHST) has an overall rating of Buy, with a price target of 12.75.
What is the Earnings Per Share (EPS TTM) of Bioharvest Sciences Inc (BHST)?
The Earnings Per Share (EPS TTM) of Bioharvest Sciences Inc (BHST) is -0.60.
